miR-20487-5p/SERCA1/MAPK/ERK Pathway Regulates Newt Limb Regeneration

Area of Science:

• Regenerative Biology
• Molecular Biology
• Cell Biology

Background:

• The Chinese fire-bellied newt (Cynops orientalis) exhibits remarkable limb regeneration capabilities.
• The precise molecular mechanisms governing this process, particularly in skeletal muscle, are not fully understood.
• Previous studies indicated elevated SERCA1 mRNA during early limb regeneration stages.

Purpose of the Study:

• To elucidate the role and regulatory mechanisms of SERCA1 in Cynops orientalis limb regeneration.
• To identify upstream regulators of SERCA1 involved in the regenerative process.
• To investigate the connection between SERCA1 and downstream signaling pathways.

Main Methods:

• Limb-amputation model in Cynops orientalis.
• Genetic manipulation: shRNA-mediated SERCA1 knockdown and Agomir therapy for miR-20487-5p.
• Pharmacological inhibition: Thapsigargin to suppress SERCA1 activity.
• Molecular analyses: miRNAomics, dual-luciferase reporter assays, Western blotting for ERK phosphorylation.
• Assessment of regenerative outcomes: cell proliferation, blastema formation, and regeneration rate.

Main Results:

• SERCA1 knockdown or inhibition significantly impaired skeletal muscle dedifferentiation, blastema formation, and cell proliferation, delaying limb regeneration.
• miR-20487-5p was identified as a negative regulator of SERCA1 expression.
• Inhibition of SERCA1 or miR-20487-5p led to reduced ERK phosphorylation, indicating a link to the MAPK/ERK pathway.
• The miR-20487-5p/SERCA1 axis plays a significant role in early newt limb regeneration.

Conclusions:

• SERCA1 is essential for initiating skeletal muscle cell dedifferentiation and blastema formation during newt limb regeneration.
• The miR-20487-5p/SERCA1 axis regulates SERCA1 expression and influences the MAPK/ERK signaling pathway.
• This study reveals a novel molecular axis critical for the early stages of newt limb regeneration, expanding understanding of regenerative mechanisms.